<img alt="" height="1" width="1" />Albireo Announces Positive Clinical Data on A3309 in Patients with Chronic ...PR Newswire (press release)A3309 is a first in class compound developed for the treatment of chronic idiopathic constipation and constipation-predominant Irritable Bowel Syndrome ...<nobr>and more »</nobr> |